Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim N01 for Platelet Recovery after UCBT
NCT06693791Phase 2Recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Dec 2024
- Primary completion
- Nov 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of romiplostim in Thrombocytopenia, sponsored by The First Affiliated Hospital of USTC. Started Dec 2024; status: recruiting.
02
Drugs
romiplostim
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT06693791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06693791.